Bio-Rad Laboratories (BIO-B) Income from Non-Controlling Interests (2009 - 2013)
Bio-Rad Laboratories (BIO-B) reported Income from Non-Controlling Interests of $21000.0 for Q1 2013, up 134.43% year-over-year from $8958.0 in Q1 2012, and up 126.58% quarter-over-quarter from -$79000.0 in Q4 2012.
Bio-Rad Laboratories (BIO-B) Income from Non-Controlling Interests (2009 - 2013) Analysis & Trends
Bio-Rad Laboratories (BIO-B) has 5 years of Income from Non-Controlling Interests data on file, last reported at $21000.0 in Q1 2013.
- Income from Non-Controlling Interests for Q1 2013 came in at $21000.0, up 134.43% year-over-year; the trailing twelve-month figure through Dec 2013 was $21000.0 (down 69.57% YoY), and the FY2013 annual result was $21000.0, down 69.57% from the prior year.
- Income from Non-Controlling Interests rose to $21000.0 in Q1 2013 per BIO-B's latest filing, from -$79000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $776000.0 in Q3 2009 and troughed at -$1.3 million in Q2 2009.
- A 5-year average of $90000.0 and a median of $4000.0 in 2012 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2011 and 2012: Income from Non-Controlling Interests tumbled 231.03% in 2011, then surged 953.85% in 2012.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $660000.0 in 2009, then sank by 95.61% to $29000.0 in 2010, then plunged by 231.03% to -$38000.0 in 2011, then plunged by 107.89% to -$79000.0 in 2012, then jumped by 126.58% to $21000.0 in 2013.
- Business Quant data shows BIO-B's Income from Non-Controlling Interests at $21000.0 in Q1 2013, -$79000.0 in Q4 2012, and -$13000.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 100,000.00 |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 21,000.00 |
| Dec 31, 2012 | -79,000.00 |
| Sep 30, 2012 | -13,000.00 |
| Jun 30, 2012 | 222,000.00 |
| Mar 31, 2012 | -61,000.00 |
| Dec 31, 2011 | -38,000.00 |
| Sep 30, 2011 | -35,000.00 |
| Jun 30, 2011 | -26,000.00 |
| Mar 31, 2011 | -101,000.00 |
| Dec 31, 2010 | 29,000.00 |
| Sep 30, 2010 | 321,000.00 |
| Jun 30, 2010 | 564,000.00 |
| Mar 31, 2010 | 531,000.00 |
| Dec 31, 2009 | 660,000.00 |
| Sep 30, 2009 | 776,000.00 |
| Jun 30, 2009 | -1.33 Mn |